Market Insights

  The   Hearing Aids Market Share  is slated to reach   US$ 10,908.4 Million   between   2024   at a   CAGR of 3.9% . The healthcare vertical, on the whole, is moving towards value-based care. In other words, the trend towards consolidation asks for better care at lower costs, with smaller hospitals showing affiliation with larger IDNs (Integrated Delivery Networks). This would be a remarkable thing with regards to the healthcare industry in the next decade. A hearing aid is a device that is designed to help a person with hearing loss by making sound audible for them. Early devices are being replaced with modern hearing aids that are easy-to-use and compact. New technology is being introduced to offer a natural quality of sound without any disturbance. Next-generation of hearing aids are being developed to tackle the common problem of current hearing aids. New hearing aids equipped with smart sensors are being introduced offer convenience to the u...

  The Remote Patient Monitoring Device Market Share is expected to be worth US$ 1,502.9 Million at a CAGR of 6.7% between 2024. With value-based reimbursement systems taking the center stage, patient engagement technology is expected to be adopted all across. The pricing analysis takes into consideration licensing fees, implementation fees, annual license maintenance fees, up-gradation and integration fees, and consulting fees. Remote patient monitoring is gaining popularity owing to the increase in chronic diseases and aging population. In the traditional healthcare setting all the data collected is lost as soon as the patient leaves the hospital and it is only found when a patient visits again. However, remote patient monitoring device helps in collecting the data and share it even from a remote location outside hospital or clinic. The concept of telemedicine is also gaining momentum. It allows remote diagnosis and treatment of patients using a telecommunication device, this redu...

Persistence Market Research (PMR) has published a new research report on the osteoarthritis treatment market titled  “Osteoarthritis Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025).”  An alarming rise in the number of osteoarthritis cases is the result of a growing geriatric population worldwide. In order to cater to the needs of the rapidly increasing geriatric population as well as the female population – given that osteoarthritis prevails mostly among these groups – the manufacturers of osteoarthritis drugs are focusing on research and development to be able to develop better and reliable drugs. As this disease is not treatable, the market is an ever growing one. In this run, the leading companies are also collaborating with other big companies in order to use their formulas and production equipment. For instance, in September 2016, Pfizer Inc. completed the acquisition of Medivation, Inc., a biopharmaceutical company focused ...

  The Hip Replacement Market Share is expected to reach US$9,128.5 Million between 2024 at a CAGR of 4.1%. Speedy development on the part of ICT does bring in new-fangled advantages like more autonomy to patients along with the promotion of interagency collaboration. As such, the ones with comorbidities and multidimensional problems would find themselves safe. This increased dependency is bound to drive the healthcare vertical going forward. A newly compiled business and commerce study done at the headquarters of Persistence Market Research (PMR) notifies that the competition in the  global hip replacement market  is stiff. And, the sheer profitability of the healthcare domain will continue to attract newer players in the near future, which will further fragment the vendor landscape. That being said, the analyst of the report has detected that a few players do hold a moderate position of strength over the rest of the competition, having established themselves over a numbe...

  The   Medical Case Management Services Market Share   is expected to be worth   US$5,155.1 Million   at a   CAGR of 3 % between   2021 . With value-based reimbursement systems taking the center stage, patient engagement technology is expected to be adopted all across. The pricing analysis takes into consideration licensing fees, implementation fees, annual license maintenance fees, up-gradation and integration fees, and consulting fees. The global  medical case management services market  features the dominance of a handful of big players that hold leading market shares. Large players are focused on expanding their presence in regional markets through partnerships and strategic collaborations with regional players.  A case in point is GENEX Services Inc. In 2014, the company acquired M Hayes – a leading case medical case management firm that specializes in workers’ compensation and disability insurance. Key players in the global medica...

  The   Fibromyalgia Treatment Market Share  is slated to reach   US$ 1.2 Bn   between   2021-2031   at a   CAGR of 6.9% . The healthcare vertical, on the whole, is moving towards value-based care. In other words, the trend towards consolidation asks for better care at lower costs, with smaller hospitals showing affiliation with larger IDNs (Integrated Delivery Networks). This would be a remarkable thing with regards to the healthcare industry in the next decade. A strong product pipeline and increasing occurrence of fibromyalgia are the major factors that are projected to boost demand for fibromyalgia treatment over the coming years. Fibromyalgia is characterized by musculoskeletal pain along with anxiety, depression, headaches, irritable bowel syndrome, memory and mood issues, sleep disorders, and fatigue. It is accepted that fibromyalgia modifies the pain sensation mechanism controlled by the brain. Get Sample Copy of Report @  https://www...